Multi Medika Internasional
PT Multi Medika Internasional Tbk engages in the distribution of disposable health care and personal care products in Indonesia. The company offers face masks, hazmat suits, surgical gowns, antigen kits, oximeter, AirPatch Aromatheraphy, shoe covers, and hair caps. It also provides food and beverage products. The company was founded in 2020 and is headquartered in Jakarta Barat, Indonesia. PT Mul… Read more
Multi Medika Internasional (MMIX) - Net Assets
Latest net assets as of December 2024: Rp180.58 Billion IDR
Based on the latest financial reports, Multi Medika Internasional (MMIX) has net assets worth Rp180.58 Billion IDR as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp407.82 Billion) and total liabilities (Rp227.24 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rp180.58 Billion |
| % of Total Assets | 44.28% |
| Annual Growth Rate | 239.9% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 754.9 |
Multi Medika Internasional - Net Assets Trend (2020–2024)
This chart illustrates how Multi Medika Internasional's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Multi Medika Internasional (2020–2024)
The table below shows the annual net assets of Multi Medika Internasional from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Rp180.58 Billion | +0.61% |
| 2023-12-31 | Rp179.48 Billion | +10.11% |
| 2022-12-31 | Rp163.00 Billion | +517.46% |
| 2021-12-31 | Rp26.40 Billion | +1851.22% |
| 2020-12-31 | Rp1.35 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Multi Medika Internasional's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 7490.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rp26.79 Billion | 14.83% |
| Common Stock | Rp60.01 Billion | 33.23% |
| Other Components | Rp93.79 Billion | 51.94% |
| Total Equity | Rp180.58 Billion | 100.00% |
Multi Medika Internasional Competitors by Market Cap
The table below lists competitors of Multi Medika Internasional ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Green Oleo S.p.A.
F:77M
|
$15.50 Million |
|
RISMA SYSTEMS A/S DK -10
F:8WX
|
$15.51 Million |
|
ASIA STAND. INTL HD-01
F:BDL1
|
$15.52 Million |
|
Monnari Trade S.A.
WAR:MON
|
$15.53 Million |
|
Lexaria Bioscience Corp
NASDAQ:LEXX
|
$15.49 Million |
|
K33 AB (publ)
ST:K33
|
$15.49 Million |
|
PASSUS S.A. ZY-1
F:71X
|
$15.49 Million |
|
Wetouch Technology Inc. Common Stock
OTCQB:WETH
|
$15.49 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Multi Medika Internasional's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 179,477,607,640 to 180,575,680,380, a change of 1,098,072,740 (0.6%).
- Net income of 1,206,972,550 contributed positively to equity growth.
- Share repurchases of 37,057,200 reduced equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rp1.21 Billion | +0.67% |
| Share Repurchases | Rp37.06 Million | -0.02% |
| Other Changes | Rp-71.84 Million | -0.04% |
| Total Change | Rp- | 0.61% |
Book Value vs Market Value Analysis
This analysis compares Multi Medika Internasional's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.79x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 372.54x to 2.79x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | Rp0.56 | Rp210.00 | x |
| 2021-12-31 | Rp11.00 | Rp210.00 | x |
| 2022-12-31 | Rp67.91 | Rp210.00 | x |
| 2023-12-31 | Rp74.78 | Rp210.00 | x |
| 2024-12-31 | Rp75.23 | Rp210.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Multi Medika Internasional utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.67%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.63%
- • Asset Turnover: 0.47x
- • Equity Multiplier: 2.26x
- Recent ROE (0.67%) is below the historical average (29.07%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 26.08% | 23.80% | 0.46x | 2.40x | Rp217.59 Million |
| 2021 | 94.88% | 13.77% | 1.66x | 4.14x | Rp22.40 Billion |
| 2022 | 14.52% | 13.52% | 0.89x | 1.21x | Rp7.37 Billion |
| 2023 | 9.20% | 9.43% | 0.54x | 1.81x | Rp-1.44 Billion |
| 2024 | 0.67% | 0.63% | 0.47x | 2.26x | Rp-16.85 Billion |
Industry Comparison
This section compares Multi Medika Internasional's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $239,166,938,610
- Average return on equity (ROE) among peers: 8.81%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Multi Medika Internasional (MMIX) | Rp180.58 Billion | 26.08% | 1.26x | $15.50 Million |
| Ikapharmindo Putramas Tbk. (IKPM) | $246.12 Billion | 2.04% | 1.00x | $4.43 Million |
| Penta Valent (PEVE) | $232.21 Billion | 15.58% | 2.90x | $9.94 Million |